Core Viewpoint - Xunfei Medical Technology's stock price increased by 6.04% to HKD 76.40, with a trading volume of HKD 13.89 million, indicating positive market sentiment towards the company [1][5]. Group 1: Shareholder Commitment - Eight shareholders, including Keda Xunfei and Kexun Venture Capital, have committed not to reduce their holdings of H-shares or unlisted shares from the end of the original lock-up period until December 29, 2026 [1][5]. - These shareholders collectively hold 55.7584 million H-shares, representing 68.25% of the total H-share capital, and 88.0682 million shares, accounting for 72.86% of the total share capital [1][5]. Group 2: Company Outlook - The company interprets the extension of the lock-up period as a sign of confidence from the shareholders regarding its future prospects [1][5]. - Shareholders will continue to review the company's performance and may consider further extending the lock-up period based on business development [1][5].